Edap TMS Sa News

EDAP TMS SA , the global leader in therapeutic ultrasound, announced today that two major hospitals in Europe have placed orders for the Ablatherm-HIFU device.

EDAP TMS SA , the global leader in therapeutic ultrasound, announced today that Dr.

Xtremepicks.com Alerts include IntegraMed America, Inc. , EDAP TMS SA , ICOP Digital, Inc.

EDAP TMS SA , the global leader in therapeutic ultrasound, announced today the first order for its Sonolith I-Sys lithotripsy device from a major U.S. lithotripsy player.

STOCK MARKETING INC PRESENTS : Force Energy Corp. EDAP TMS S.A. 8x8, Inc. Entropic Communications, Inc.

EDAP TMS SA , the global leader in therapeutic ultrasound, announced today that the French regulatory organization AFSSAPS has authorized a Phase I clinical study to evaluate High Intensity Focused Ultrasound technology in patients with metastatic liver cancer.

EDAP TMS S.A. , the global leader in therapeutic ultrasound, announced today the launch of an intensified communication and education strategy in France, aimed at increasing physician and patient awareness of Ablatherm-HIFU as a therapeutic option for localized prostate cancer.

LYON, France, Sept. 10, 2009 -- EDAP TMS S.A. , the global leader in therapeutic ultrasound, announced today the expansion of Ablatherm-HIFU into new territories as part of the Company's global growth strategy: * The Taiwan Department of Health officially approved the Ablatherm-HIFU device as a minimally invasive treatment for patients with ...

EDAP TMS SA , the global leader in therapeutic ultrasound, announced today that Rob Michiels was appointed to its Board of Directors, effective July 16, 2009.

EDAP TMS SA , the global leader in therapeutic ultrasound, announced today that Dr.

EDAP TMS SA , the global leader in therapeutic ultrasound, announced today that its High Intensity Focused Ultrasound technology was showcased at the 2nd Annual International Workshop on Focal Therapy and Imaging in Prostate Kidney Cancer.

EDAP TMS SA , the global leader in therapeutic ultrasound, announced today the Ministry of Health in Argentina has approved Ablatherm-HIFU as a minimally invasive treatment option for patients with localized prostate cancer.